Your browser doesn't support javascript.
loading
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer.
De Schepper, Maxim; Vincent-Salomon, Anne; Christgen, Matthias; Van Baelen, Karen; Richard, François; Tsuda, Hitoshi; Kurozumi, Sasagu; Brito, Maria Jose; Cserni, Gabor; Schnitt, Stuart; Larsimont, Denis; Kulka, Janina; Fernandez, Pedro Luis; Rodríguez-Martínez, Paula; Olivar, Ana Aula; Melendez, Cristina; Van Bockstal, Mieke; Kovacs, Aniko; Varga, Zsuzsanna; Wesseling, Jelle; Bhargava, Rohit; Boström, Pia; Franchet, Camille; Zambuko, Blessing; Matute, Gustavo; Mueller, Sophie; Berghian, Anca; Rakha, Emad; van Diest, Paul J; Oesterreich, Steffi; Derksen, Patrick W B; Floris, Giuseppe; Desmedt, Christine.
Afiliação
  • De Schepper M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Vincent-Salomon A; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France.
  • Christgen M; Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Van Baelen K; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Richard F; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Tsuda H; Department of Basic Pathology, National Defense Medical College Hospital, Tokorozawa, Saitama, Japan.
  • Kurozumi S; Department of Breast Surgery, International University of Health and Welfare, Narita, Chiba, Japan.
  • Brito MJ; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • Cserni G; Department of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary & Department of Pathology, Albert Szent-Györgyi Medical Center, University of Szeged, Szeged, Hungary.
  • Schnitt S; Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Larsimont D; Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Kulka J; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Pest, Hungary.
  • Fernandez PL; Hospital German Trias i Pujol, Universidad Autonoma de Barcelona, Barcelona, Spain.
  • Rodríguez-Martínez P; Hospital German Trias i Pujol, Universidad Autonoma de Barcelona, Barcelona, Spain.
  • Olivar AA; University Hospital Doctor Josep Trueta, Girona, Spain.
  • Melendez C; University Hospital Doctor Josep Trueta, Girona, Spain.
  • Van Bockstal M; Department of Pathology, Cliniques universitaires Saint-Luc Bruxelles, Woluwé-Saint-Lambert, Brussels, Belgium.
  • Kovacs A; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Varga Z; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Wesseling J; Divisions of Molecular Pathology and Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Bhargava R; Department of Pathology, UPMC Magee-Womens Hospital, Pittsburgh, PA, USA.
  • Boström P; Department of Pathology, Turku University Hospital and University of Turku, Turku, Finland.
  • Franchet C; Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
  • Zambuko B; Department of Pathology, Sir Ketumile Masire Teaching Hospital, University of Botswana, Gaborone, Botswana.
  • Matute G; Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana, Medellín, Colombia.
  • Mueller S; Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Berghian A; Department of Biopathology, Centre Henri Becquerel, Rouen, France.
  • Rakha E; Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus Hucknall Road, Nottingham, UK.
  • van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Derksen PWB; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Floris G; Department of Pathology, University Hospitals Leuven, UZ Leuven, Leuven, Belgium. giuseppe.floris@uzleuven.be.
  • Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. christine.desmedt@kuleuven.be.
Mod Pathol ; 35(12): 1812-1820, 2022 12.
Article em En | MEDLINE | ID: mdl-35922548
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Assunto principal: Neoplasias da Mama / Carcinoma in Situ / Carcinoma Lobular / Carcinoma Ductal de Mama Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Female / Humans Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Assunto principal: Neoplasias da Mama / Carcinoma in Situ / Carcinoma Lobular / Carcinoma Ductal de Mama Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Female / Humans Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica